ResearchReal-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea.
ResearchEligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea.
Dec 18, 2023Clinical TrialHigh Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial.Written by 1 Roon author & 12 others Via Journal of Cardiac Failure
ResearchDeterminants of Guideline-Directed Medical Therapy Implementation During Heart Failure Hospitalization.
ResearchRandomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.
ResearchImpact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial.
ResearchDisconnect between the effects of serelaxin on renal function and outcome in acute heart failure.
ResearchCardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF.
ResearchMineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure.
ResearchMortality Prediction in Patients With or Without Heart Failure Using a Machine Learning Model.
ResearchGlobal longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction.
ResearchInternational Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review.
ResearchA machine learning-derived risk score predicts mortality in East Asian patients with acute heart failure.